Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.

about

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.

Item

http://www.wikidata.org/entity/Q43987893

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Metapristone (RU486 metabolite ...... GFR-mediated PI3K/AKT pathway.

@en

Metapristone

@nl

type

Item

label

Metapristone (RU486 metabolite ...... GFR-mediated PI3K/AKT pathway.

@en

Metapristone

@nl

prefLabel

Metapristone (RU486 metabolite ...... GFR-mediated PI3K/AKT pathway.

@en

Metapristone

@nl

P1476

Metapristone (RU486 metabolite ...... EGFR-mediated PI3K/AKT pathway

@en

P2093

Aixiao Xu

http://www.w3.org/2001/XMLSchema#string

Fan Chen

http://www.w3.org/2001/XMLSchema#string

Guirong Zheng

http://www.w3.org/2001/XMLSchema#string

Hongning Chen

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jianguo Xu

http://www.w3.org/2001/XMLSchema#string

Jingwei Shao

http://www.w3.org/2001/XMLSchema#string

Ning Zheng

http://www.w3.org/2001/XMLSchema#string

Tao Li

http://www.w3.org/2001/XMLSchema#string

Yusheng Lu

http://www.w3.org/2001/XMLSchema#string

P2860

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

Global cancer statistics, 2012

Untangling the ErbB signalling network

Proliferation, cell cycle and apoptosis in cancer

Roles of caveolin-1 on anoikis resistance in non small cell lung cancer

P304

78351-78364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18640

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lee Jia

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29108234

http://www.w3.org/2001/XMLSchema#string

P932

5667967

http://www.w3.org/2001/XMLSchema#string